Stoke Therapeutics Inc

Stoke Therapeutics Inc. is a biopharmaceutical company. It develops antisense oligonucleotide medicines to treat genetic diseases. The company's product candidate consists of STK-001 which is to treat Dravet syndrome, a severe and progressive genetic epilepsy. Stoke Therapeutics Inc. is based in Bedford, Massachusetts.

Address Details

Address: 45 WIGGINS AVENUE

City: BEDFORD

State: MA

Country: USA

Zip Code: 01730